{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:07:17Z","timestamp":1760299637998},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the utility of using 90-day as an adjunct to 30-day mortality rates after surgical cytoreduction for serous ovarian cancer and to compare them across hospitals of differing case volumes over time.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We performed a retrospective cohort study using the National Cancer Database of women undergoing cytoreductive surgery for high-grade serous carcinoma between 2004 and 2012. The primary outcome of the study was mortality rate by hospital volume. The secondary outcome was to evaluate the performance of hospital rankings based on 30- and 90-day mortality rates. Hospitals were categorized by cases per year as low volume (10 or fewer), intermediate (11\u201320), high (21\u201330), and ultra-high (31 or more).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>A total of 24,827 women from 602 hospitals were included. Overall 30-day mortality was 2.1% (95% CI 1.95\u20132.3) compared with 90-day mortality of 5.1% (95% CI 4.8\u20135.4%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). For each hospital volume category, the 90-day mortality was approximately double that of the 30-day mortality. Substituting 90-day in place of 30-day mortality for hospital ranking, 57 hospitals (9.5%) changed ranks (26 worsened and 31 improved). Based on the logistic regression model (after controlling for age, race\u2013ethnicity, income, Charlson comorbidity index, insurance status, hospital volume, distance from place of residence to the hospital, receipt of neoadjuvant chemotherapy, and year of diagnosis), care at the ultra\u2013high-volume centers was an independent predictor of lower odds of death at 90 days [adjusted odds ratios (OR) 0.60, 95% CI 0.38\u20130.96, <jats:italic toggle=\"yes\">P<\/jats:italic>=.034] but not at 30 days (adjusted OR 0.64, 95% CI 0.35\u20131.18).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Compared with low-volume centers, ultra\u2013high-volume centers are associated with significantly lower 30- and 90-day risk-adjusted mortality. The 90-day mortality rate is double that of the 30-day rate and may be a better metric for assessing the initial quality of care for patients with ovarian cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002140","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T14:41:44Z","timestamp":1499784104000},"page":"305-314","source":"Crossref","is-referenced-by-count":11,"title":["Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery"],"prefix":"10.1097","volume":"130","author":[{"given":"Ryan J.","family":"Spencer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari E.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J.","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel W.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Kevin","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitanshu","family":"Uppal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrclinonc.2015.26","article-title":"A framework for a personalized surgical approach to ovarian cancer","volume":"12","author":"Nick","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/annonc\/mdv500","article-title":"Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology\/Gynecologic Oncology Group study","volume":"27","author":"Tewari","year":"2016","journal-title":"Ann Oncol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamasurg.2013.5143","article-title":"Beyond 30-day mortality: aligning surgical quality with outcomes that patients value","volume":"149","author":"Schwarze","year":"2014","journal-title":"JAMA Surg"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/bjs.8813","article-title":"Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types","volume":"99","author":"Damhuis","year":"2012","journal-title":"Br J Surg"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.athoracsur.2010.01.069","article-title":"The 30- versus 90-day operative mortality after pulmonary resection","volume":"89","author":"Bryant","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-014-4036-4","article-title":"The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base","volume":"21","author":"Swanson","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1203\/00006450-200211000-00011","article-title":"The risk of mortality or cerebral palsy in twins: a collaborative population-based study","volume":"52","author":"Scher","year":"2002","journal-title":"Pediatr Res"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40273-014-0224-0","article-title":"A primer on marginal effects\u2014part II: health services research applications","volume":"33","author":"Onukwugha","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0000000000001215","article-title":"Doubling of 30-day mortality by 90 days after esophagectomy: a critical measure of outcomes for quality improvement","volume":"263","author":"In","year":"2016","journal-title":"Ann Surg"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2015.12.021","article-title":"Ovarian cancer outcomes: predictors of early death","volume":"140","author":"Urban","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1200\/JCO.2012.43.2906","article-title":"Failure to rescue as a source of variation in hospital mortality for ovarian cancer","volume":"30","author":"Wright","year":"2012","journal-title":"J Clin Oncol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2015.06.013","article-title":"Improving NCCN guideline-adherent care for ovarian cancer: value of an intervention","volume":"138","author":"Dottino","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMsa012337","article-title":"Hospital volume and surgical mortality in the United States","volume":"346","author":"Birkmeyer","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCOUTCOMES.111.964460","article-title":"Limitations of ranking lists based on cardiac surgery mortality rates","volume":"5","author":"Siregar","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2008.11.011","article-title":"Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in The Netherlands","volume":"112","author":"Vernooij","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2010.05.025","article-title":"The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm","volume":"118","author":"Bristow","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnci\/djj018","article-title":"Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection","volume":"98","author":"Schrag","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1245\/s10434-015-4938-9","article-title":"Is it time to centralize ovarian cancer care in the United States?","volume":"23","author":"Cowan","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2016.05.025","article-title":"Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival\u2014a population-based cohort study","volume":"142","author":"Dahm-K\u00e4hler","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.22561","article-title":"Centralization of care for patients with advanced-stage ovarian cancer","volume":"109","author":"Bristow","year":"2007","journal-title":"Cancer"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201708000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:39:39Z","timestamp":1689104379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201708000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002140","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}